Molecular Diagnostic for Infectious Diseases Market Size, Segments, and Trends by 2030
Molecular Diagnostic for Infectious Diseases Market: Strategic Insights
Molecular Diagnostic for Infectious Diseases Market
-
CAGR (2022 - 2030)12.5% -
Market Size 2022
US$ 6.88 Billion -
Market Size 2030
US$ 17.61 Billion
Market Dynamics
GROWTH DRIVERS
- Surging prevalence of infectious disease propels the need for molecular diagnostic technology over traditional techniques
FUTURE TRENDS
- Molecular diagnostics for infectious diseases in personalized medicine is likely to remain a key trend in the market
OPPORTUNITIES
- Collaborative efforts by scientific communities in different countries to manage infectious diseases will likely create significant opportunities for the market
Key Players
- F Hoffmann La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc
- bioMerieux SA
- Danaher Corp
- Hologic Inc
- Siemens Healthineers AG
- Bruker Corp
- Molzym GmbH Co KG
- DiaSorin SpA
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type - Point-of-Care Testing
- Laboratory Testing
End User - Point-of-Care Testing
- Laboratory Testing
Application - Point-of-Care Testing
- Laboratory Testing
Disease Type - Point-of-Care Testing
- Laboratory Testing
Get Free Sample For